The impact of stereoisomerism in bioequivalence studies

Journal of Pharmaceutical Sciences

Volumn 87, Issue 7, 1998, Pages 797-802

  Midha, Kamal K ^a   Mckay, Gordon ^a   Rawson, Maureen J ^a   Hubbard, John W ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXEPIN; FLURBIPROFEN; HYDROXYCHLOROQUINE; IBUPROFEN; KETOPROFEN; NADOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; NORDOXEPIN; NORTRIPTYLINE; OMEPRAZOLE; PROPAFENONE;

BIOEQUIVALENCE; DEPRESSION; DRUG ABSORPTION; DRUG FORMULATION; DRUG METABOLISM; HEART ARRHYTHMIA; HUMAN; INFLAMMATION; ORAL DRUG ADMINISTRATION; SHORT SURVEY; STEREOISOMERISM;

EID: 0031848993     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9703683     Document Type: Article

References (63)

1. Ariens, E. Eur. J. Clin. Pharmacol. 1984, 26, 663-668.
2. Ariens, E.; Wuis, E. Clin. Pharmacol. Ther. 1987, 42, 361-363.
3. Evans, A.; Nation, R.; Sansom, L.; Bochner, F.; Somogyi, A. Br. J. Clin. Pharmacol. 1988, 26, 771-780.
4. Evans, A. Eur. J. Clin. Pharmacol. 1992, 42, 237-256.
5. Caldwell, J. J. Clin. Pharmacol. 1992, 32, 925-929.
6. Campbell, D. Eur. J. Drug Metab. Pharmacokinet. 1990, 15, 109-125.
7. Gibaldi, M. Chirality 1993, 5, 407-413.
8. Jamali, F.; Mehvar, R.; Pasutto, F. J. Pharm. Sci. 1989, 78, 695-715.
9. Nation, R. Clin. Pharmacokinet. 1994, 27, 249-255.
10. Tucker, G.; Lennard, M. Pharmacol. Ther. 1990, 45, 309-329.
11. Hooper, W. D.; Dickinson, R. G.; Gal, J. Biopharm. Drug Dispos. 1992, 13, 383-385.
12. Jamali, F. Biopharm. Drug Dispos. 1992, 13, 385-387.
13. Birkett, D. Clin. Exp. Pharmacol. Physiol. 1989, 16, 479-483.
14. Hooper, W. D. Proc. West Pharmacol. Soc. 1993, 36, 167-171.
15. Jamali, F. J. Clin. Pharmacol. 1992, 32, 930-934.
16. Karim, A. J. Clin. Pharmacol. 1996, 36, 490-499.
17. Marzo, A. Boll. Chim. Farm. 1993, 132, 267-271.
18. Nation, R.; Samsom, L. Pharmacol. Ther. 1994, 1994, 41-55.
19. Nitchuk, W. J. Clin. Pharmacol. 1992, 32, 953-954.
20. Shah, V. P.; Midha, K. K.; Dighe, S.; McGilveray, I. J.; Skelly, J. P.; Yacobi, A.; Layloff, T.; Viswanathan, C. T.; Cook, C. E.; McDowall, R. D.; et al. Eur. J. Drug Metab. Pharmacokinet. 1991, 16, 249-255.
21. Wechter, W. J. Clin. Pharmacol. 1992, 32, 915-916.
22. Laganiere, S. In The impact of stereochemistry on drug development and use; Aboul-Eneim, H., Wainer, I., Eds.; John Wiley and Sons Inc.: New York, 1997; Vol. 142.
23. Midha, K.; Ormsby, E.; Hubbard, J.; McKay, G.; Hawes, E.; Gavalas, L.; McGilveray, I. J. Pharm. Sci. 1993, 82, 138-144.
24. Schuirmann, D. J. J. Pharmacokinet. Biopharm. 1987, 15, 657-680.
25. Midha, K.; Rawson, M.; Hubbard, J.; Ormsby, E. In BioInternational 2: Bioavailability, bioequivalence and pharmacokinetic studies. International conference of F.I.P. "Bio-International '94"; Munich, Germany, June 15-17, 1994; Blume, H., Midha, K., Eds.; Medpharm Scientific Publishers: Stuttgart, 1995; pp 123-128.
26. Blume, H. H.; Midha, K. K. J. Pharm. Sci. 1993, 82, 1186-1189.
27. Midha, K. K.; Hubbard, J. W.; Yeung, P. K.-F.; Ormsby, E.; McKay, G.; Hawes, E. M.; Korchinski, E. D.; Gurnsey, T.; Rawson, M. J.; Schwede, R. In Bio-International: bioavailability, bioequivalence and pharmacokinetics; international conference of F.I.P. "Bio-International '92"; Bad Homburg, Germany, May 20-22, 1992; Midha, K. K., Blume, H. H., Eds.; Medpharm Scientific Publishers: Stuttgart, 1993; pp 53-68.
28. Jamali, F.; Collins, D. S.; Berry, B. W.; Holder, S.; Cheung, R.; McColl, K.; Cheung, H. Biopharm. Drug Dispos. 1991, 12, 435-45.
29. Jamali, F.; Singh, N.; Pasutto, F.; Russell, A.; Coutts, R. Pharm. Res. 1988, 5, 40-43.
30. Jamali, F.; Berry, B.; Tehrani, M.; Russell, A. J. Pharm. Sci. 1988, 77, 666-669.
31. Qureshi, S.; Caille, G.; Lacasse, Y.; McGilveray, I. Pharmaceut. Res. 1994, 11, 1669-1672.
32. Anderson, T. Clin. Pharmacokinet. 1991, 15, 195-212.
33. Foster, R.; Jamali, F.; Russell, A.; Alballa, S. J. Pharm. Sci. 1988, 77, 70-83.
34. Hollman, M.; Brode, E.; Hotz, D.; Kaumeier, S.; Kehrhahn, O. Arzneim.-Forsch. (Drug Res.) 1983, 33, 763-770.
35. Connolly, S.; Lebsack, C.; Winkle, R.; Harrison, D.; Kates, R. Clin. Phamacol. Ther. 1984, 36, 163-168.
36. Siddoway, L.; McAllister, C.; Wang, T.; Bergstrand, R.; Roden, D.; Wilkinson, G.; Woosley, R. Circulation 1983, 68 (Suppl. III), 64.
37. Koytchev, R.; Alken, R. G.; Mayer, O.; Bohm, R.; Ellrich, A.; Waldnerkolblin, R. G. Arzneim.-Forsch. (Drug Res.) 1995, 45, 542-545.
38. Srinivas, N. R.; Barr, W. H.; Shyu, W. C.; Mohandoss, E.; Chow, S.; Staggers, J.; Balan, G.; Belas, F. J.; Blair, I. A.; Barbhaiya, R. H. J. Pharm. Sci. 1996, 85, 299-303.
39. Frishman, W. New Engl. J. Med. 1981, 305, 678-682.
40. Pinder, R. M.; Brogden, R. N.; Speight, T. M.; Avery, G. S. Drugs 1977, 13, 161-218.
41. Faulkner, R. D.; Pitts, W. M.; Lee, C. S.; Lewis, W. A.; Fann, W. E. Clin. Pharmacol. Ther. 1983, 34, 509-15.
42. Green, D. J. Clin. Psychiat. 1978, 39, 481-482.
43. Ward, N. G.; Bloom, V. L.; Wilson, L.; Raskind, M.; Raisys, V. A. J. Cli.n Psychopharmacology 1982, 2, 126-8.
44. Rosseel, M. T.; Bogaert, M. G.; Claeys, M. J. Pharm. Sci. 1978, 67, 802-805.
45. Hrdina, P. D.; Bakish, D.; Swenson, S.; Lapierre, Y. D. Ther. Drug Monit. 1990, 12, 129-33.
46. Midha, K. K.; Hubbard, J. W.; McKay, G.; Hawes, E. M.; Korchinski, E. D.; Gurnsey, T.; Cooper, J. K.; Schwede, R. Eur. J. Clin. Pharmacol. 1992, 42, 539-544.
47. Ghabrial, H.; Prakash, C.; Tacke, U. G.; Blair, I. A.; Wilkinson, G. R. Drug Metab. Dispos. 1991, 19, 596-9.
48. Yan, Y.-H.; Hubbard, J.; McKay, G.; Midha, K. Xenobiotica 1997, 27, 1245-1257.
49. Tucker, G.; Rostami, A.; Jackson, P. Metabolite measurements in bioequivalence studies: Theoretical considerations; Medpharm Scientific Publishers: Stuttgart, 1993; pp 163-170.
50. Midha, K. K.; Hubbard, J. W.; Rawson, M.; Schwede, R. Eur. J. Pharm. Sci. 1996, 4, 133-138.
51. Young, R. C. Psychopharmacol. Bull. 1991, 27, 521-532.
52. Nordin, C.; Bertilsson, L. Clin. Pharmacokinet. 1995, 28, 26-40.
53. Mellstrom, B.; Bertilsson, L.; Sawe, J.; Schultz, H.-U.; Sjoqvist, F. Clin. Pharmacol. Therap. 1981, 30, 189-193.
54. Mellstrom, B.; Bertilsson, L.; Birgesson, C.; Goransson, M.; von Bahr, C. Drug Metab. Dispos. 1983, 11, 115-119.
55. Dahl, M.-L.; Nordin, C.; Bertilsson, L. Therap. Drug Monitor. 1991, 13, 189-194.
56. Midha, K. K.; Hubbard, J. W.; Mckay, G.; Rawson, M.; Schwede, R. J. Pharm. Sci. 1995, 84, 1265-1266.
57. Blume, H. H.; Mcgilveray, I. J.; Midha, K. K. Eur. J. Pharm. Sci. 1995, 3, 113-124.
58. Brocks, D. R.; Skeith, K. J.; Johnston, C.; Emamibafrani, J.; Davis, P.; Russell, A. S.; Jamali, F. J. Clin. Pharmacol. 1994, 34, 1088-1097.
59. McLachlan, A. J.; Tett, S. E.; Cutler, D. J.; Day, R. O. Chirality 1994, 6, 360-364.
60. McLachlan, A. J.; Tett, S. E.; Cutler, D. J.; Day, R. O. Br. J. Clin. Pharmacol. 1993, 36, 78-81.
61. Tett, S. E.; McLachlan, A. J.; Cutler, D. J.; Day, R. O. Chirality 1994, 6, 355-9.
62. Midha, K.; Hubbard, J.; Rawson, M.; McKay, G.; Schwede, R. Eur. J. Pharm. Sci. 1996, 4, 283-292.
63. Midha, K. K.; Hubbard, J. W.; Rawson, M. J.; Gavalas, L. Eur. J. Pharm. Sci. 1994, 2, 351-363.